Total Payments
$6,224
2024 Payments
$1,019
Companies
32
Transactions
328
Medicare Patients
13,937
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$6,085 (97.8%)
Education$139.02 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,085 | 325 | 97.8% |
| Education | $139.02 | 3 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $1,765 | 80 | $0 (2024) |
| ABBVIE INC. | $848.83 | 50 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $780.33 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $481.46 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $333.94 | 19 | $0 (2024) |
| Lilly USA, LLC | $245.20 | 14 | $0 (2024) |
| Incyte Corporation | $220.55 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $205.62 | 11 | $0 (2024) |
| PFIZER INC. | $181.60 | 13 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $141.98 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,019 | 49 | GENZYME CORPORATION ($221.10) |
| 2023 | $811.82 | 39 | GENZYME CORPORATION ($274.12) |
| 2022 | $894.61 | 39 | GENZYME CORPORATION ($375.65) |
| 2021 | $581.35 | 32 | GENZYME CORPORATION ($203.16) |
| 2020 | $538.16 | 28 | GENZYME CORPORATION ($327.66) |
| 2019 | $976.52 | 52 | GENZYME CORPORATION ($207.98) |
| 2018 | $803.00 | 49 | Regeneron Healthcare Solutions, Inc. ($168.51) |
| 2017 | $600.32 | 40 | Novartis Pharmaceuticals Corporation ($114.38) |
All Payment Transactions
328 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.56 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.26 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $32.58 | General |
| 09/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.05 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Dermatology | ||||||
| 07/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immunology | ||||||
| 06/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Immunology | ||||||
| 06/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Immunology | ||||||
| 06/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,842 | 7,430 | $710,692 | $318,031 |
| 2022 | 20 | 3,477 | 6,778 | $642,790 | $283,777 |
| 2021 | 19 | 3,415 | 6,576 | $632,195 | $285,919 |
| 2020 | 19 | 3,203 | 6,120 | $593,099 | $265,329 |
Total Patients
13,937
Total Services
26,904
Medicare Billing
$1.2M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,096 | 1,834 | $246,569 | $112,488 | 45.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 466 | 604 | $100,689 | $47,224 | 46.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 415 | 561 | $83,828 | $36,811 | 43.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 569 | 847 | $84,159 | $30,854 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 248 | 293 | $55,781 | $24,616 | 44.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 400 | 2,455 | $23,744 | $12,190 | 51.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 200 | 241 | $20,208 | $9,569 | 47.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 107 | 187 | $13,884 | $7,132 | 51.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 37 | 59 | $14,776 | $7,130 | 48.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 45 | 52 | $11,382 | $5,329 | 46.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 32 | 40 | $10,630 | $5,118 | 48.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 61 | 61 | $10,269 | $4,595 | 44.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 14 | 31 | $6,058 | $2,826 | 46.7% |
| 10040 | Acne surgery | Office | 2023 | 31 | 33 | $5,676 | $2,471 | 43.5% |
| 69100 | Biopsy of ear | Office | 2023 | 32 | 36 | $5,164 | $2,167 | 42.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 21 | 23 | $4,263 | $1,999 | 46.9% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $3,207 | $1,498 | 46.7% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $2,976 | $1,327 | 44.6% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 23 | 23 | $3,125 | $1,071 | 34.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 12 | 12 | $2,224 | $818.36 | 36.8% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 11 | 14 | $2,081 | $796.36 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,052 | 1,772 | $241,612 | $108,030 | 44.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 443 | 585 | $98,596 | $44,900 | 45.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 546 | 824 | $83,002 | $30,555 | 36.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 296 | 395 | $60,265 | $25,819 | 42.8% |
About Dr. Tricia Andrews, M.D
Dr. Tricia Andrews, M.D is a Dermatology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427031509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tricia Andrews, M.D has received a total of $6,224 in payments from pharmaceutical and medical device companies, with $1,019 received in 2024. These payments were reported across 328 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,085).
As a Medicare-enrolled provider, Andrews has provided services to 13,937 Medicare beneficiaries, totaling 26,904 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Jacksonville, FL
- Active Since 11/22/2005
- Last Updated 10/08/2018
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1427031509
Products in Payments
- DUPIXENT (Biological) $2,016
- COSENTYX (Biological) $380.12
- DUPIXENT (Drug) $347.72
- SKYRIZI (Biological) $316.01
- RINVOQ (Biological) $253.51
- TALTZ (Drug) $226.29
- Humira (Biological) $186.94
- Sotyktu (Drug) $183.53
- DUPIXENT DUPILUMAB INJECTION (Biological) $183.33
- EUCRISA (Drug) $181.60
- TREMFYA (Drug) $179.73
- Otezla (Drug) $130.98
- OPZELURA (Drug) $121.55
- NAFTIN (Drug) $92.72
- COSENTYX (Drug) $78.77
- Tremfya (Drug) $71.87
- KERYDIN (Drug) $67.43
- Skyrizi (Biological) $57.68
- Cordran (Drug) $54.45
- Zoryve (Drug) $51.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jacksonville
Dr. Pearl Kwong, Md Phd, MD PHD
Dermatology — Payments: $2.8M
Dermatology $2.8M
Michael Bernhardt, Md, MD
Dermatology — Payments: $702,961
Dermatology $702,961
Kristen Stewart, M.d, M.D
Dermatology — Payments: $107,300
Dermatology $107,300
Jason Sluzevich, Md, MD
Dermatology — Payments: $61,523
Dermatology $61,523
Dr. Douglas Robins, Md, MD
Dermatology — Payments: $24,873
Dermatology $24,873
Jean Mcclintock, Md, MD
Dermatology — Payments: $14,036
Dermatology $14,036